ストックスクリーナーアプリを入手
0.4776
4.48%
-0.0224
アフターアワーズ：
.48
0.0024
+0.50%
前日終値:
$0.50
開ける：
$0.5
24時間の取引高:
219.49K
Relative Volume:
1.09
時価総額：
$15.97M
収益：
$7.11M
当期純損益:
$-41.28M
株価収益率:
-0.3461
EPS:
-1.38
ネットキャッシュフロー:
$-26.84M
1週間 パフォーマンス:
-7.03%
1か月 パフォーマンス:
-30.78%
6か月 パフォーマンス:
-63.54%
1年 パフォーマンス:
-59.53%
1日の値動き範囲:
$0.45
$0.5297
1週間の範囲:
$0.45
$0.6764
52週間の値動き範囲:
$0.45
$2.2299
Co Diagnostics Inc Stock (CODX) Company Profile
名前
Co Diagnostics Inc
セクター
電話
(801) 278-9769
住所
4049 SOUTH HIGHLAND DRIVE, SALT LAKE CITY
CODX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
CODX
Co Diagnostics Inc
|
0.4776 | 15.97M | 7.11M | -41.28M | -26.84M | -1.38 |
|
ABT
Abbott Laboratories
|
129.89 | 225.41B | 41.95B | 13.40B | 6.35B | 7.65 |
|
BSX
Boston Scientific Corp
|
95.37 | 140.36B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
363.66 | 138.70B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
92.33 | 118.30B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
67.95 | 39.77B | 5.72B | 4.17B | 259.90M | 6.97 |
Co Diagnostics Inc Stock (CODX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2022-08-12 | ダウングレード | Sidoti | Buy → Neutral |
| 2021-12-29 | 開始されました | Sidoti | Buy |
| 2021-03-29 | ダウングレード | Maxim Group | Buy → Hold |
| 2020-05-20 | アップグレード | Maxim Group | Hold → Buy |
| 2020-05-18 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-03-09 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-03-03 | ダウングレード | Maxim Group | Buy → Hold |
すべてを表示
Co Diagnostics Inc (CODX) 最新ニュース
Co-Diagnostics stock hits 52-week low at $0.45 amid market challenges - Investing.com India
Co-Diagnostics, Inc. Announces Fourth Quarter and Full Year 2024 Earnings Release Date and Webcast - BioSpace
Co-Diagnostics Sets Date for Crucial Year-End 2024 Financial Results - StockTitan
Co-Diagnostics Inc.’s Securities Class Action - Global Legal Chronicle
Co-Diagnostics Inc expected to post a loss of 34 cents a shareEarnings Preview - TradingView
Co-Diagnostics wins dismissal of class action lawsuit - TipRanks
Federal Court Validates Co-Diagnostics' COVID Test ClaimsWhat This Legal Win Means - StockTitan
Co-Diagnostics (CODX) Projected to Post Earnings on Thursday - Defense World
Analyzing ResMed (NYSE:RMD) and Co-Diagnostics (NASDAQ:CODX) - Defense World
Co-Diagnostics stock hits 52-week low at $0.49 amid market challenges - Investing.com Australia
Co-Diagnostics stock hits 52-week low at $0.49 amid market challenges By Investing.com - Investing.com South Africa
Co-Diagnostics, Inc. and CoSara to Host HPV and Cancer Symposium on International HPV Day 2025 - PR Newswire
Comparing Globus Medical (NYSE:GMED) and Co-Diagnostics (NASDAQ:CODX) - Defense World
Co-Diagnostics stock hits 52-week low at $0.65 amid market challenges - Investing.com Australia
Co-Diagnostics stock hits 52-week low at $0.65 amid market challenges By Investing.com - Investing.com South Africa
Penny Stock Co-Diagnostics Withdraws FDA Application For COVID-19 Test, Plans To Submit Enhanced Version - Yahoo Finance
Infectious Disease Diagnostics Market (2024-2035): Trends, Growth Drivers, and Future Outlook - PharmiWeb.com
Looking For A Good Stock? Let This Co-Diagnostics Inc (NASDAQ: CODX) Analysis Help. - Stocks Register
Analyzing Co-Diagnostics (NASDAQ:CODX) and CVRx (NASDAQ:CVRX) - Defense World
CODX CLASS ACTION: Hagens Berman, National Trial Attorneys, Encourages Co-Diagnostics (CODX) Investors with Significant Losses to Contact the Firm’s Attorneys, Securities Fraud Class Action Filed - ACCESS Newswire
Co-Dx withdraws FDA application to update COVID-19 test By Investing.com - Investing.com Australia
Co-Diagnostics Announces Intention To Submit Enhanced Version Of Covid-19 Test To FDA - Marketscreener.com
Co-Diagnostics Plans to Seek FDA Clearance for Enhanced Version of COVID-19 Test - Marketscreener.com
Co-Diagnostics Withdraws FDA Application for Covid Test -February 21, 2025 at 04:48 pm EST - Marketscreener.com
Co-Dx withdraws FDA application to update COVID-19 test - Investing.com India
Co-Diagnostics, Inc. Announces Intention to Submit Enhanced Version of COVID-19 Test to FDA for 510(k) Clearance - WV News
Co-Diagnostics (CODX) Stock Price, News & Analysis - MarketBeat
Co-Diagnostics Inc (CODX) stock analysis: A comprehensive overview - US Post News
Infectious Disease Diagnostics Market worth $31.5 billion by 2028 - WICZ
CODX INVESTOR ALERT: Hagens Berman, National Trial Attorneys, Encourages Co-Diagnostics (CODX) Investors with Significant Losses to Contact the Firm’s Attorneys, Securities Class Action Filed - ACCESS Newswire
Co-Diagnostics, Inc. Reports Second Quarter 2024 Financial Resul - GuruFocus.com
Co-Diagnostics, Inc. to Exhibit at BioUtah's 2025 Life Sciences Day on the Hill - Nasdaq
Co-Diagnostics, Inc.: Live from Silicon Slopes - Nasdaq
CODX FINAL DEADLINE: ROSEN, A LEADING FIRM, Encourages Co-Diagnostics, Inc. Investors to Contact Firm Before Important August 17 Deadline in Securities Class Action Seeking Recovery of Investor LossesCODX - AccessWire
Quest Diagnostics (DGX) Stock Price, News & Analysis - MarketBeat
Jane Street Group LLC Makes New $55,000 Investment in Co-Diagnostics, Inc. (NASDAQ:CODX) - Defense World
CODX (Co-Diagnostics) 5-Year Dividend Growth Rate : 0.00% (As of Sep. 2024) - GuruFocus.com
Co-Diagnostics faces potential Nasdaq delisting over share price - Investing.com
Co-Diagnostics faces potential Nasdaq delisting over share price By Investing.com - Investing.com Nigeria
Co-Diagnostics, Inc. to Participate at the Nasdaq Live from MarketSite Broadcast at Silicon Slopes 2025 - PR Newswire
Head to Head Contrast: Co-Diagnostics (NASDAQ:CODX) vs. Vasamed (OTCMKTS:VSMD) - Defense World
Co-Diagnostics (NASDAQ:CODX) and Aethlon Medical (NASDAQ:AEMD) Critical Review - Defense World
Co-Diagnostics, Inc. Announces Second Quarter 2024 Earnings Rele - GuruFocus.com
Financial Review: Co-Diagnostics (NASDAQ:CODX) & Endologix (OTCMKTS:ELGXQ) - Defense World
Co-Diagnostics stock hits 52-week low at $0.79 amid market challenges - Investing.com
CoSara Diagnostics inaugurates new oligo facility in Ranoli, Gujarat - BSI bureau
Co-Diagnostics, Inc. and CoSara Diagnostics to Inaugurate New Oligo Facility - Marketscreener.com
Co-Diagnostics, Inc. Announces Third Quarter 2024 Earnings Release Date and Webcast - The Eastern Progress Online
Make in India: CoSara Diagnostics to open oligo facility in Ranoli - Medical Buyer
Co-Diagnostics, Inc. to Accompany Utah Governor and WTC Utah on Trade Mission to South Korea and Japan - The Eastern Progress Online
Co Diagnostics Inc (CODX) 財務データ
収益
当期純利益
現金流量
EPS
3.40%
0.89%
大文字化:
|
ボリューム (24 時間):